GANX CIK: 1819411

Gain Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.4
FY22:
−14.7
FY23:
−18.9
FY24:
−18.9
FY25:
−18.5
Change from FY21 to FY24
millions USD
FY21:
−0.09
FY22:
−14.8
FY23:
10.2
FY24:
4.98
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
41.8
FY22:
−0.08
FY23:
12.6
FY24:
13.0
FY25:
28.4
millions USD
FY21:
29.4
FY22:
−29.6
FY23:
4.49
FY24:
−1.41
FY25:
10.5
(positive)
Change from FY21 to FY24
millions USD
FY21:
−12.5
FY22:
−14.8
FY23:
−18.9
FY24:
−18.9
FY25:
–

All amounts in millions USD Data source:SEC EDGAR